PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1226720
PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1226720
Sacroiliac joint fusion is a minimally invasive procedure that involves a small incision. Professionals perform the procedure under image guidance and insert implants across the sacroiliac joint to provide stability. The growing demand for minimally invasive procedures, as well as the rising incidences of injuries due to the increasing number of road accidents, are important contributing factors to the market growth of sacroiliac joint fusion. For instance, as per the data of World Health Organization 2022, approximately 1.3 Million people die due to road accidents every year.
The Sacroiliac Joint Fusion Market is expected to grow at a steady rate of around 19% owing to the rising number of spine and hip surgeries and frequent product launches. For instance, in year 2020, Genesys Spine announced the launch of its sacroiliac joint fusion system. The system consists of partially threaded and fully threaded implants designed to secure the sacroiliac joint and minimize micro-motion enabling bone fusion.
Based on the indication, the market has been categorized into degenerative sacroiliitis, sacral disruption, and trauma. Among them, the degenerative sacroiliitis segment holds a dominant share of the market. Degenerative sacroiliitis is an inflammation of one or both sacroiliac joints situated where the lower spine and pelvis connect. The rising prevalence of the disease, along with the increasing awareness about the severity of the disease attributed to the segmental growth of degenerative sacroiliitis.
Based on the treatment type, the market has been categorized into surgery, injections, and RF ablation. Among them, the RF ablation segment is expected to witness the fastest growth during the forecast period. Radiofrequency ablation provides moderate pain relief and helps restore function for daily movements. The rising incidences of injuries and the increasing demand for minimally invasive procedures are the responsible factors for the fast growth of the segment.
Based on the end-user, the market has been categorized into hospitals, ambulatory surgical centers, and others. Among them, the hospital category is to witness higher adoption of sacroiliac joint fusion during the forecast period. The increasing hospitalization and rising number of surgeries in hospitals are the important reasons for the segmental growth of hospitals in the sacroiliac joint fusion market.
For a better understanding of the market adoption of the sacroiliac joint fusion industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is anticipated hold a dominant market share in 2020. This is mainly due to the presence of major market players in the region, advancements in therapeutic surgeries, and the growing population with a rising prevalence of back pain. For instance, as per the National Center for Health Statistics, in 2022, 58.9% of adults are living with back pain. Back pain is the most common type of pain, affecting nearly 2 out of 5 U.S. adults.
Some of the major players operating in the market are SI-BONE, Inc.; PainTEQ; FOUNDATION FUSION SOLUTION, LLC.; SIGNUS Medizintechnik GmbH; Globus Medical; Medtronic; Orthofix US LLC; Life Spine, Inc.; Camber Spine Technologies, LLC; and CoreLink, LLC.